Demand for spirometers is increasing significantly amid growing prevalence of respiratory diseases. According to Coherent Market Insights, the global spirometer industry is set to thrive at 9.5% CAGR during the forecast period, totaling US$ 2168.2 million by 2030.
Koninklijke Philips N.V., Smiths Medical, SCHILLER, Medicare Systems, Vyaire Medical, Inc., LabTech, and Midmark Corporation are few leading spirometer manufacturers. Top players are constantly innovating to develop advanced solutions with improved features.
Companies are launching new user-friendly spirometers with features like wireless connectivity and AI-powered analysis. They are striving to ensure that their spirometers meet stringent quality standards.
Many players are partnering and collaborating with healthcare providers and other organizations to expand their reach. Acquisitions and mergers are also becoming popular in the spirometry industry.
In November 2021, Cipla Limited introduced Spirofy on World COPD Day to strengthen its lung leadership position. It is India’s first pneumotach based portable, wireless spirometer designed for diagnosis of asthma and COPD.
In November 2021, SCHILLER set new standards in portable spirometry with the introduction of SPIROVIT SP-1 G2. The new solution is a portable spirometer with ultrasonic technology and an integrated thermal printer. It is an all-in-one solution in lung function testing.
In March 2021, Vyaire Medical introduced AioCare, a novel remote mobile spirometer. The new mobile spirometry system is designed to diagnose pulmonary diseases like COPD and asthma accurately.
Key Factors Propelling Spirometer Industry Growth
The future of spirometer industry looks bright. This is due to rising incidence of respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). Growing need for early detection of respiratory diseases to reduce mortality rates is also fueling spirometer demand.
There has been an alarming rise in the cases of respiratory diseases like asthma during the last few years. According to the World Health Organization (WHO), asthma affected around 262 million people in 2019. This is expected to propel demand for spirometers.
Spirometry has become the gold standard for pulmonary function testing owing to its ability to provide accurate and repeatable assessments. This non-invasive test measures lung function by assessing the volume and speed of air a person can inhale and exhale. It is widely employed for diagnosing and managing conditions like COPD and asthma.
Rising awareness about respiratory health is also positively impacting the spirometer industry. People often opt for spirometry tests to ensure optimal lung function.
Increasing geriatric population is also fueling spirometer sales. Older people are more prone to respiratory issues, which drives the demand for spirometry testing.
Regional Insights
North America is set to retain its dominance in the global spirometer industry through 2030. This is due to rising cases of asthma and COPD, growing interest in non-invasive tests, and strong presence of leading spirometer manufacturers.
Availability of advanced spirometers is also informing growth in North America. Many United States-based companies are constantly launching novel solutions like digital spirometers and wireless spirometers.
